Thrombosis et diathesis haemorrhagica, 0340-6245

Journal

More filtering options
  1. 2019
  2. Platelet Indices and Risk of Death and Cardiovascular Events: Results from a Large Population-Based Cohort Study

    Patti, G., Di Martino, G., Fabrizio Ricci, Renda, G., Gallina, S., Viktor Hamrefors, Olle Melander, Sutton, R., Gunnar Engström, De Caterina, R. & Artur Fedorowski, 2019 Nov, In : Thrombosis and Haemostasis. 119, 11, p. 1773-1784

    Research output: Contribution to journalArticle

  3. The Ultimate Murine Model of Immune Thrombocytopaenia

    John W. Semple & Kapur, R., 2019, In : Thrombosis and Haemostasis. 119, 3, p. 353-354 2 p.

    Research output: Contribution to journalDebate/Note/Editorial

  4. 2018
  5. Genetic Variation in the Syntaxin-Binding Protein STXBP5 in Type 1 von Willebrand Disease Patients

    Lind-Halldén, C., Manderstedt, E., Carlberg, D., Lethagen, S. & Halldén, C., 2018 Jul 4, In : Thrombosis and Haemostasis.

    Research output: Contribution to journalArticle

  6. A Genome-wide Study of Common and Rare Genetic Variants Associated with Circulating Thrombin Activatable Fibrinolysis Inhibitor

    Stanne, T. M., Olsson, M., Lorentzen, E., Pedersen, A., Gummesson, A., Gils, A., Jood, K., Gunnar Engström, Olle Melander, Declerck, P. J. & Jern, C., 2018, In : Thrombosis and Haemostasis. 118, 2, p. 298-308

    Research output: Contribution to journalArticle

  7. 2017
  8. Risk Factors for the Progression from Low to High Titres in 260 Children with Severe Haemophilia A and Newly Developed Inhibitors

    Mancuso, M. E., Fischer, K., Santagostino, E., Oldenburg, J., Platokouki, H., Escuriola-Ettingshausen, C., Rivard, G. E., Cid, A. R., Carcao, M., Ljung, R., Petrini, P., Altisent, C., Kenet, G., Kurnik, K., Auerswald, G., Chambost, H., Mäkipernaa, A., Molinari, A. C., Williams, M., van den Berg, H. M. & 1 othersEuropean Pediatric Network for Haemophilia Management (PedNet) the REMAIN (REal life MAnagement of children with INhibitors) Study Group, 2017 Dec, In : Thrombosis and Haemostasis. 117, 12, p. 2274-2282

    Research output: Contribution to journalArticle

  9. Bleeding complications and mortality in warfarin-treated VTE patients, dependence of INR variability and iTTR

    Sandén, P., Renlund, H., Peter J. Svensson & Själander, A., 2017 Jan 1, In : Thrombosis and Haemostasis. 117, 1, p. 27-32 6 p.

    Research output: Contribution to journalArticle

  10. Extracellular nucleic acids in immunity and cardiovascular responses: Between alert and disease

    Preissner, K. T. & Heiko Herwald, 2017, In : Thrombosis and Haemostasis. 117, 7, p. 1272-1282 11 p.

    Research output: Contribution to journalReview article

  11. Obesity/insulin resistance rather than liver fat increases coagulation factor activities and expression in humans

    Lallukka, S., Luukkonen, P. K., Zhou, Y., Isokuortti, E., Leivonen, M., Juuti, A., Hakkarainen, A., Marju Orho-Melander, Lundbom, N., Olkkonen, V. M., Lassila, R. & Yki-Järvinen, H., 2017, In : Thrombosis and Haemostasis. 117, 2, p. 286-294 9 p.

    Research output: Contribution to journalArticle

  12. Paracelsus, poison, and colistin

    Heiko Herwald, 2017, In : Thrombosis and Haemostasis. 117, 9, p. 1661 1 p.

    Research output: Contribution to journalDebate/Note/Editorial

  13. The importance of genetic factors for the development of arthropathy: A longitudinal study of children and adolescents with haemophilia A

    Gomperts, E. D., Schwarz, J., Donfield, S. M., Lail, A. E., Jan Astermark, Keith Hoots, W., Winkler, C. A. & Erik Berntorp, 2017, In : Thrombosis and Haemostasis. 117, 2, p. 277-285 9 p.

    Research output: Contribution to journalArticle

  14. 2016
  15. Diagnostic potential of plasma microRNA signatures in patients with deep-vein thrombosis

    Xiao Wang, Kristina Sundquist, Johan L. Elf, Strandberg, K., Peter J. Svensson, Hedelius, A., Palmér, K., Ashfaque A. Memon, Jan Sundquist & Bengt Zöller, 2016 Aug 1, In : Thrombosis and Haemostasis. 116, 2, p. 328-336 9 p.

    Research output: Contribution to journalArticle

  16. Increased inhibitor incidence in severe haemophilia A since 1990 attributable to more low titre inhibitors

    van den Berg, H. M., Hashemi, S. M., Fischer, K., Petrini, P., Rolf Ljung, Rafowicz, A., Carcao, M., Auerswald, G., Kurnik, K., Kenet, G. & Santagostino, E., 2016 Apr 1, In : Thrombosis and Haemostasis. 115, 4, p. 729-737 9 p.

    Research output: Contribution to journalArticle

  17. BRCA2 gene mutations and coagulation-associated biomarkers

    Perez-Segura, P., Zamorano-León, J. J., Acosta, D., Santos-Sancho, J. M., Modrego, J., Caldés, T., De La Hoya, M., Díaz-Rubio, E., Díaz-Millán, I., De Las Heras, N., Zalba, L. A. R., Lahera, V., Olle Melander & Farré, A. L., 2016, In : Thrombosis and Haemostasis. 115, 2, p. 415-423 9 p.

    Research output: Contribution to journalArticle

  18. Practical considerations in choosing a factor VIII prophylaxis regimen: Role of clinical phenotype and trough levels.

    Rolf Ljung, Fischer, K., Carcao, M., Santagostino, E., Manco-Johnson, M. J. & Mathew, P., 2016, In : Thrombosis and Haemostasis. 115, 5, p. 913-920

    Research output: Contribution to journalReview article

  19. 2015
  20. Active but inoperable thrombin is accumulated in a plasma protein layer surrounding Streptococcus pyogenes.

    Naudin, C., Hurley, S., Erik Malmström, Plug, T., Oonagh Shannon, Meijers, J. C. M., Mörgelin, M., Lars Björck & Heiko Herwald, 2015, In : Thrombosis and Haemostasis. 114, 4, p. 717-726

    Research output: Contribution to journalArticle

  21. Amino acid residues in the laminin G domains of protein S involved in tissue factor pathway inhibitor interaction.

    Somajo, S., Ahnström, J., Fernandez-Recio, J., Gierula, M., Villoutreix, B. O. & Björn Dahlbäck, 2015, In : Thrombosis and Haemostasis. 113, 5, p. 976-987

    Research output: Contribution to journalArticle

  22. Binding of vitronectin and Factor H to Hic contributes to immune evasion of Streptococcus pneumoniae serotype 3.

    Kohler, S., Hallström, T., Singh, B., Kristian Riesbeck, Sparta, G., Zipfel, P. F. & Hammerschmidt, S., 2015, In : Thrombosis and Haemostasis. 113, 1, p. 125-142

    Research output: Contribution to journalArticle

  23. B regulatory cells are increased in hypercholesterolaemic mice and protect from lesion development via IL-10

    Strom, A. C., Cross, A. J., Cole, J. E., Blair, P. A., Leib, C., Goddard, M. E., Rosser, E. C., Park, I., Nilsson, A. H., Jan Nilsson, Mauri, C. & Monaco, C., 2015, In : Thrombosis and Haemostasis. 114, 4, p. 835-847

    Research output: Contribution to journalArticle

  24. Coagulation factor XIII: a multifunctional transglutaminase with clinical potential in a range of conditions

    Dickneite, G., Heiko Herwald, Korte, W., Allanore, Y., Denton, C. P. & Cerinic, M. M., 2015, In : Thrombosis and Haemostasis. 113, 4, p. 686-697

    Research output: Contribution to journalReview article

  25. Genetic aspects of thrombotic disease

    Garcia de Frutos, P. & Bengt Zöller, 2015, In : Thrombosis and Haemostasis. 114, 5, p. 883-884

    Research output: Contribution to journalDebate/Note/Editorial

  26. Safety and efficacy of well managed warfarin: A report from the Swedish quality register Auricula

    Sjogren, V., Grzymala-Lubanski, B., Renlund, H., Friberg, L., Lip, G. Y. H., Peter Svensson & Sjalander, A., 2015, In : Thrombosis and Haemostasis. 113, 6, p. 1370-1377

    Research output: Contribution to journalArticle

  27. 2014
  28. Clopidogrel metaboliser status based on point-of-care CYP2C19 genetic testing in patients with coronary artery disease.

    David Erlinge, James, S., Duvvuru, S., Jakubowski, J. A., Wagner, H., Varenhorst, C., Tantry, U. S., Brown, P. B., Small, D., Moser, B. A., Sundseth, S., Walker, J. R., Winters, K. J. & Gurbel, P. A., 2014, In : Thrombosis and Haemostasis. 111, 5, p. 943-950

    Research output: Contribution to journalArticle

  29. Fibrinogen measurement in cardiac surgery with cardiopulmonary bypass: Analysis of repeatability and agreement of Clauss method within and between six different laboratories

    Solomon, C., Baryshnikova, E., Tripodi, A., Schlimp, C. J., Schoechl, H., Cadamuro, J., Dag Winstedt, Asmis, L. & Ranucci, M., 2014, In : Thrombosis and Haemostasis. 112, 1, p. 109-117

    Research output: Contribution to journalArticle

  30. Inflammatory role and prognostic value of platelet chemokines in acute coronary syndrome

    Blanchet, X., Cesarek, K., Brandt, J., Heiko Herwald, Teupser, D., Kuechenhoff, H., Karshovska, E., Mause, S. F., Siess, W., Wasmuth, H., Soehnlein, O., Koenen, R. R., Weber, C. & von Hundelshausen, P., 2014, In : Thrombosis and Haemostasis. 112, 6, p. 1277-1287

    Research output: Contribution to journalArticle

  31. Targeted mass spectrometry analysis of neutrophil-derived proteins released during sepsis progression.

    Erik Malmström, Davidova, A., Mörgelin, M., Adam Linder, Larsen, M., Qvortrup, K., Pontus Nordenfelt, Oonagh Shannon, Dzupova, O., Holub, M., Johan Malmström & Heiko Herwald, 2014, In : Thrombosis and Haemostasis. 112, 6, p. 1230-1243

    Research output: Contribution to journalArticle

  32. The coagulation system and its function in early immune defense.

    van der Poll, T. & Heiko Herwald, 2014, In : Thrombosis and Haemostasis. 112, 4, p. 640-648

    Research output: Contribution to journalArticle

  33. The effect of CYP2C19 gene polymorphisms on the pharmacokinetics and pharmacodynamics of prasugrel 5-mg, prasugrel 10-mg and clopidogrel 75-mg in patients with coronary artery disease

    Gurbel, P. A., Bergmeijer, T. O., Tantry, U. S., ten Berg, J. M., Angiolillo, D. J., James, S., Lindahl, T. L., Peter Svensson, Jakubowski, J. A., Brown, P. B., Duvvuru, S., Sundseth, S., Walker, J. R., Small, D., Moser, B. A., Winters, K. J. & David Erlinge, 2014, In : Thrombosis and Haemostasis. 112, 3, p. 589-597

    Research output: Contribution to journalArticle

  34. 2013
  35. Anti-inflammatory, anti-coagulant, anti-biotic?

    Heiko Herwald, 2013, In : Thrombosis and Haemostasis. 109, 4, p. 582-582

    Research output: Contribution to journalDebate/Note/Editorial

  36. Enhanced active metabolite generation and platelet inhibitionwith prasugrel compared to clopidogrel regardless of genotype in thienopyridine metabolic pathways.

    Oscar Braun, Angiolillo, D. J., Ferreiro, J. L., Jakubowski, J. A., Winters, K. J., Effron, M. B., Duvvuru, S., Costigan, T. M., Sundseth, S., Walker, J. R., Saucedo, J. F., Kleiman, N. S. & Varenhorst, C., 2013, In : Thrombosis and Haemostasis. 110, 6, p. 1223-1231

    Research output: Contribution to journalArticle

  37. Molecular basis of coagulation factor V deficiency caused by the R1698W inter-domain mutation

    Calzavarini, S., Villoutreix, B. O., Lunghi, B., Livaja Koshiar, R., Bernardi, F. & Björn Dahlbäck, 2013, In : Thrombosis and Haemostasis. 110, 1, p. 31-38

    Research output: Contribution to journalArticle

  38. Old genes and new genes: The evolution of the kallikrein locus.

    Åke Lundwall, 2013, In : Thrombosis and Haemostasis. 109, 6

    Research output: Contribution to journalReview article

  39. 2012
  40. Factor VIIa binding to endothelial cell protein C receptor: Differences between mouse and human systems

    Sen, P., Clark, C. A., Gopalakrishnan, R., Hedner, U., Esmon, C. T., Pendurthi, U. R. & Rao, L. V. M., 2012, In : Thrombosis and Haemostasis. 107, 5, p. 951-961

    Research output: Contribution to journalArticle

  41. Farnesyl pyrophosphate is an endogenous antagonist to ADP-stimulated P2Y12 receptor-mediated platelet aggregation.

    Högberg, C., Olof Gidlöf, Deflorian, F., Jacobson, K. A., Abdelrahman, A., Müller, C. E., Björn Olde & David Erlinge, 2012, In : Thrombosis and Haemostasis. 108, 1, p. 119-132

    Research output: Contribution to journalArticle

  42. Management consensus guidance for the use of rivaroxaban - an oral, direct factor Xa inhibitor

    Turpie, A. G. G., Kreutz, R., Llau, J., Bo Norrving & Haas, S., 2012, In : Thrombosis and Haemostasis. 108, 5, p. 876-886

    Research output: Contribution to journalArticle

  43. Small and large PROS1 deletions but no other types of rearrangements detected in patents with protein S deficiency

    Lind-Hallden, C., Dahlen, A., Andreas Hillarp, Bengt Zöller, Björn Dahlbäck & Hallden, C., 2012, In : Thrombosis and Haemostasis. 108, 1, p. 94-100

    Research output: Contribution to journalArticle

  44. Translational platelet research in patients with coronary artery disease: hat are the rnalor knowledge gaps?

    Gurbel, P. A., Roe, M. T., Jakubowski, J. A., Shah, S., David Erlinge, Goodman, S. G., Huber, K., Chan, M. Y., Cornel, J. H., Tantry, U. S. & Ohman, E. M., 2012, In : Thrombosis and Haemostasis. 108, 1, p. 12-20

    Research output: Contribution to journalReview article

  45. 2011
  46. A large deletion identified in a Swedish family with type 1 VWD

    Johansson, A. M., Lanke, E., Torbjörn Säll, Lethagen, S. & Halldén, C., 2011, In : Thrombosis and Haemostasis. 105, 4, p. 733-734

    Research output: Contribution to journalLetter

  47. Binding characteristics of thrombin-activatable fibrinolysis inhibitor to streptococcal surface collagen-like proteins A and B

    Seron, M. V., Plug, T., Marquart, J. A., Marx, P. F., Heiko Herwald, de Groot, P. G. & Meijers, J. C. M., 2011, In : Thrombosis and Haemostasis. 106, 4, p. 609-616

    Research output: Contribution to journalArticle

  48. Inhibitors in haemophilia A - Prevention, current management and personalised therapy perspectives

    Erik Berntorp, Escuriola-Ettingshausen, C., Khair, K., Kreuz, W., Montano, C. & Zozulya, N., 2011, In : Thrombosis and Haemostasis. 105, 3, p. A4-A14

    Research output: Contribution to journalDebate/Note/Editorial

  49. Modern treatment options for von Willebrand disease and haemophilia B - What are the benefits for the patients?

    Giangrande, P., von Depka, M., Kessler, C. M., Kannicht, C. & Rolf Ljung, 2011, In : Thrombosis and Haemostasis. 106, 3, p. 5-14

    Research output: Contribution to journalArticle

  50. 2010
  51. Safety and tolerability of an immediate-release formulation of theoral direct thrombin inhibitor AZD0837 in the prevention of stroke and systemic embolism in patients with atrial fibrillation.

    Bertil Olsson, Rasmussen, L. H., Tveit, A., Jensen, E., Wessman, P., Panfilov, S. & Wåhlander, K., 2010, In : Thrombosis and Haemostasis. 103, Jan 13, p. 604-612

    Research output: Contribution to journalArticle

  52. The D2194G mutation is responsible for increased levels of FV1 in carriers of the factor V R2 haplotype

    Yamazaki, T., Okada, H., Balling, K., Björn Dahlbäck & Nicolaes, G., 2010, In : Thrombosis and Haemostasis. 104, 4, p. 860-861

    Research output: Contribution to journalLetter

  53. 2009
  54. Fibrin gel structure obtained with a FVIIa analogue with enhanced FX-activating potential in haemophilia

    He, S., Ezban, M., Bark, N., Persson, E. & Hedner, U., 2009, In : Thrombosis and Haemostasis. 102, 4, p. 790-792

    Research output: Contribution to journalLetter

  55. Platelets interact with bacterial pathogens.

    Oonagh Shannon, 2009, In : Thrombosis and Haemostasis. 102, 4, p. 613-614

    Research output: Contribution to journalArticle

  56. Relation between atrial fibrillatory rate and markers of inflammation and haemostasis in persistent human atrial fibrillation

    Tveit, A., Bollmann, A., Seljeflot, I., Husser, D., Martin Stridh, Leif Sörnmo, Arnesen, H., Olsson, S. B. & Smith, P., 2009, In : Thrombosis and Haemostasis. 101, 3, p. 601-603

    Research output: Contribution to journalArticle

  57. The effects of hyperglycaemia on thrombin-activatable fibrinolysis inhibitor

    Verkleij, C. J. N., Nieuwdorp, M., Gerdes, V. E. A., Mörgelin, M., Meijers, J. C. M. & Marx, P. F., 2009, In : Thrombosis and Haemostasis. 102, 3, p. 460-468

    Research output: Contribution to journalArticle

  58. 2008
  59. High-dose erythropoietin alters platelet reactivity and bleeding time in rodents in contrast to the neuroprotective variant carbamyl-erythropoietin (CEPO)

    Agnete Kirkeby, Torup, L., Bochsen, L., Kjalke, M., Abel, K., Theilgaard-Monch, K., Johansson, P. I., Bjørn, S. E., Gerwien, J. & Leist, M., 2008 Apr, In : Thrombosis and Haemostasis. 99, 4, p. 720-728 9 p.

    Research output: Contribution to journalArticle

  60. Distribution of von Willebrand factor levels in young women with and without bleeding symptoms. Influence of ABO blood group and promoter haplotypes

    Lethagen, S., Andreas Hillarp, Ekholm, C., Mattson, E., Halldén, C. & Britt Friberg, 2008, In : Thrombosis and Haemostasis. 99, 6, p. 1013-1018

    Research output: Contribution to journalArticle

  61. FactorVIIa and its potential therapeutic use in bleeding-associated pathologies

    Hedner, U., 2008, In : Thrombosis and Haemostasis. 100, 4, p. 557-562

    Research output: Contribution to journalArticle

  62. Greater reduction of platelet activation markers and platelet-monocyte aggregates by prasugrel compared to clopidogrel in stable coronary artery disease

    Oscar Braun, Johnell, M., Varenhorst, C., James, S., Brandt, J. T., Jakubowski, J. A., Winters, K. J., Wallentin, L., David Erlinge & Siegbahn, A., 2008, In : Thrombosis and Haemostasis. 100, 4, p. 626-633

    Research output: Contribution to journalArticle

  63. Surgical evaluation of a recombinant factorVIII prepared using a plasma/albumin-free method: Efficacy and safety of Advate in previously treated patients

    Negrier, C., Shapiro, A., Erik Berntorp, Pabinger, I., Tarantino, M., Retzios, A., Schroth, P. & Ewenstein, B., 2008, In : Thrombosis and Haemostasis. 100, 2, p. 217-223

    Research output: Contribution to journalArticle

  64. 2007
  65. Coagulation factorV and thrombophilia: Background and mechanisms

    Segers, K., Björn Dahlbäck & Nicolaes, G. A. F., 2007, In : Thrombosis and Haemostasis. 98, 3, p. 530-542

    Research output: Contribution to journalArticle

  66. Haemostasis, vascular biology, and infectious agents.

    Heiko Herwald, 2007, In : Thrombosis and Haemostasis. 98, 3, p. 483-484

    Research output: Contribution to journalLetter

  67. Low soluble thrombomodulin activity and antigen is associated with a family history of heart disease while a high level is associated with a personal history of heart disease in type 2 diabetes

    Konstantoulas, C. J., Cooper, J. A., Öhlin, A-K., Humphries, S. E., Goodall, A. H., Toh, C-H., Mather, H. & Ireland, H., 2007, In : Thrombosis and Haemostasis. 97, 1, p. 161-164

    Research output: Contribution to journalLetter

  68. Murine monoclonal antibodies against murine uPA receptor produced in gene-deficient mice: inhibitory effects on receptor-mediated uPA activity in vitro and in vivo

    Pass, J., Annika Jögi, Lund, I. K., Rono, B., Rasch, M. G., Gardsvoll, H., Lund, L. R., Ploug, M., Romer, J., Dano, K. & Hoyer-Hansen, G., 2007, In : Thrombosis and Haemostasis. 97, 6, p. 1013-1022

    Research output: Contribution to journalArticle

  69. The tale of protein S and C4b-binding protein, a story of affection

    Björn Dahlbäck, 2007, In : Thrombosis and Haemostasis. 98, 1, p. 90-96

    Research output: Contribution to journalArticle

  70. 2006
  71. A common origin of the 4143insA ADAMTS13 mutation

    Schneppenheim, R., Hovinga, J. A. K., Becker, J., Budde, U., Diana Karpman, Brockhaus, W., Hrachovinova, I., Korczowski, B., Oyen, F., Rittich, S., von Rosen, J., Tjonnfjord, G. E., Pimanda, J. E., Wienker, T. F. & Laemmle, B., 2006, In : Thrombosis and Haemostasis. 96, 1, p. 3-6

    Research output: Contribution to journalArticle

  72. Activation of human polymorphonuclear neutrophils by streptolysin O from Streptococcus pyogenes leads to the release of proinflammatory mediators.

    Nilsson, M. E., Ole E Sørensen, Mörgelin, M., Weineisen, M., Sjöbring, U. & Heiko Herwald, 2006, In : Thrombosis and Haemostasis. 95, 6, p. 982-990

    Research output: Contribution to journalArticle

  73. Prothrombin deficiency caused by compound heterozygosity for two novel mutations in the prothrombin gene associated with a bleeding tendency

    Stanchev, H., Philips, M., Villoutreix, BO., Aksglaede, L., Lethagen, S. & Thorsen, S., 2006, In : Thrombosis and Haemostasis. 95, 1, p. 195-198

    Research output: Contribution to journalArticle

  74. Trousseau's syndrome - what is the evidence? A population-based autopsy study

    Ogren, M., Bergqvist, D., Wahlander, K., Eriksson, H. & Sternby, N., 2006, In : Thrombosis and Haemostasis. 95, 3, p. 541-545

    Research output: Contribution to journalArticle

  75. 2005
  76. Mortality rates and risk factors for asymptomatic deep vein thrombosis in medical patients

    Vaitkus, P. T., Leizorovicz, A., Cohen, A. T., Turpie, A. G. G., Olsson, C-G., Goldhaber, S. Z. & G, P. T. S., 2005, In : Thrombosis and Haemostasis. 93, 1, p. 76-79

    Research output: Contribution to journalArticle

  77. Protein Z and protein Z-dependent protease inhibitor - Determinants of levels and risk of venous thrombosis

    Al-Shanqeeti, A., Vlieg, AV., Erik Berntorp, Rosendaal, FR. & Broze, GJ., 2005, In : Thrombosis and Haemostasis. 93, 3, p. 411-413

    Research output: Contribution to journalArticle

  78. Rebuttal: Meta-analysis of the relationship of factor V Leiden and intrauterine growth restriction - based on solid evidence?

    Lindqvist, P., Juan Merlo, Dudding, T. & Attia, J., 2005, In : Thrombosis and Haemostasis. 94, 1, p. 230-232

    Research output: Contribution to journalLetter

  79. Value of ventilation/perfusion SPECT detecting extensive pulmonary embolism in a patient with pneumonia.

    Marika Bajc, Olsson, C-G., Björn Jonson & Albrechtsson, U., 2005, In : Thrombosis and Haemostasis. 93, 5, p. 993-994

    Research output: Contribution to journalArticle

  80. 2004
  81. INR calibration of Owren-type prothrombin time based on the relationship between PT% and INR utilizing normal plasma samples

    Lindahl, TL., Egberg, N., Andreas Hillarp, Odegaard, OR., Edlund, B., Svensson, J., Sandset, PM. & Ranby, M., 2004, In : Thrombosis and Haemostasis. 91, 6, p. 1223-1231

    Research output: Contribution to journalArticle

  82. 2003
  83. Pooled analysis of prognostic impact of uPA and PAI-I in breast cancer patients

    Look, M., van Putten, W., Duffy, M., Harbeck, N., Christensen, IJ., Thomssen, C., Kates, R., Spyratos, F., Fernö, M., Eppenberger-Castori, S., Sweep, CGJF., Ulm, K., Peyrat, JP., Martin, PM., Magdelenat, H., Brunner, N., Duggan, C., Lisboa, BW., Bendah, PO., Quillien, V. & 20 othersDaver, A., Ricolleau, G., Meijer-Van Gelder, M., Manders, P., Fiets, WE., Blankenstein, M., Broet, P., Romain, S., Daxenbichler, G., Windbichler, G., Cufer, T., Borstnar, S., Kueng, W., Beex, L., Klijn, J., O'Higgins, N., Eppenberger, U., Janicke, F., Schmitt, M. & Foekens, J., 2003, In : Thrombosis and Haemostasis. 90, 3, p. 538-548

    Research output: Contribution to journalArticle

  84. 2002
  85. Genetic and phenotypic variability between families with hereditary protein S deficiency

    Rezende, SM., Lane, DA., Bengt Zöller, Mille-Baker, B., Laffan, M., Björn Dahlbäck & Simmonds, RE., 2002, In : Thrombosis and Haemostasis. 87, 2, p. 258-265

    Research output: Contribution to journalArticle

  86. Multicentre evaluation of IL Test (TM) Free PS: A fully automated assay to quantify Free Protein S

    Serra, J., Sales, M., Chitolie, A., Domenech, P., Rossi, E., Borrell, M. & Björn Dahlbäck, 2002, In : Thrombosis and Haemostasis. 88, 6, p. 975-983

    Research output: Contribution to journalArticle

  87. Platelets: a new target for gene therapy of haemophilia B.

    Brown, M. A., 2002, In : Thrombosis and Haemostasis. 87, 3, p. 362-363

    Research output: Contribution to journalLetter

  88. Rapid intracellular degradation of a truncated mutant protein S (Q522X)

    Yamazaki, T., Saito, H. & Björn Dahlbäck, 2002, In : Thrombosis and Haemostasis. 87, 1, p. 171-172

    Research output: Contribution to journalLetter

  89. 2001
  90. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism - Pooled analysis of 8 case-control studies including 2310 cases and 3204 controls

    Emmerich, J., Rosendaal, F. R., Cattaneo, M., Margaglione, M., De Stefano, V., Cumming, T., Arruda, V., Andreas Hillarp & Reny, J-L., 2001, In : Thrombosis and Haemostasis. 86, 3, p. 809-816

    Research output: Contribution to journalArticle

  91. Extracellular nucleotides ATP and UTP induce a marked acute release of tissue-type plasminogen activator in vivo in man

    Hrafnkelsdottir, T., David Erlinge & Jern, S., 2001, In : Thrombosis and Haemostasis. 85, 5, p. 875-881

    Research output: Contribution to journalArticle

  92. No increased risk of venous thrombosis in women taking tranexamic acid

    Erik Berntorp, Follrud, C. & Lethagen, S., 2001, In : Thrombosis and Haemostasis. 86, 2, p. 714-715

    Research output: Contribution to journalLetter

  93. 2000
  94. Impact, diagnosis and treatment of von Willebrand disease

    Sadler, J. E., Mannucci, P. M., Erik Berntorp, Bochkov, N., Boulyjenkov, V., Ginsburg, D., Meyer, D., Peake, I., Rodeghiero, F. & Srivastava, A., 2000, In : Thrombosis and Haemostasis. 84, 2, p. 160-174

    Research output: Contribution to journalArticle

  95. 1999
  96. Control of smooth muscle cell proliferation - The role of the basement membrane

    Hedin, U., Roy, J., Tran, P. K., K. Lundmark & Rahman, A., 1999 Dec 1, In : Thrombosis and Haemostasis. 82, SUPPL. 1, p. 23-26 4 p.

    Research output: Contribution to journalArticle

Previous 1 2 Next